Mid
J
JNJAI Stock Diagnostic Report
J&J granted China nod for oral psoriasis pill developed with Protagonist
An oral psoriasis treatment developed by Johnson & Johnson (J&J) together with its development partner Protagonist has received approval in China.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time